Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) rose 5.2% during trading on Friday . The stock traded as high as $91.45 and last traded at $88.11. Approximately 13,619,652 shares changed hands during mid-day trading, an increase of 2% from the average daily volume of 13,370,095 shares. The stock had previously closed at $83.75.
Wall Street Analysts Forecast Growth
TEM has been the subject of several research reports. Wolfe Research started coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective for the company. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. TD Cowen reaffirmed a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Needham & Company LLC reissued a “buy” rating and issued a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Finally, William Blair downgraded Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Tempus AI has an average rating of “Moderate Buy” and an average target price of $58.55.
Check Out Our Latest Stock Analysis on Tempus AI
Tempus AI Stock Performance
Insider Buying and Selling
In related news, major shareholder Bradley A. Keywell sold 265,000 shares of Tempus AI stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the transaction, the insider now directly owns 15,218,365 shares of the company’s stock, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Eric P. Lefkofsky sold 80,388 shares of the company’s stock in a transaction on Friday, February 7th. The stock was sold at an average price of $67.53, for a total value of $5,428,601.64. Following the sale, the chief executive officer now owns 5,293,005 shares of the company’s stock, valued at approximately $357,436,627.65. This represents a 1.50 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,229,449 shares of company stock valued at $102,293,124 in the last 90 days.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. ARK Investment Management LLC grew its stake in Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. NEA Management Company LLC lifted its position in shares of Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after buying an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. grew its position in shares of Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Finally, Franklin Resources Inc. grew its position in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. 24.22% of the stock is owned by institutional investors.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
- Five stocks we like better than Tempus AI
- How to Start Investing in Real Estate
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Earnings Per Share Calculator: How to Calculate EPS
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.